Andere talen Biocept, Inc.

Aandelen

BIOCQ

US09072V6002

Beurs gesloten - OTC Markets Andere beurzen 16:15:28 15-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0001 ^USD	0,00%		0,00%	-99,76%

2023	Biocept, Inc. Faillissement aangevraagd	CI
2023	Biocept, Inc. Kondigt de volledige inschrijving aan van 40 proefpersonen met borstkanker of niet-kleincellige longkanker	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Motion for Asset Sale Approved for Biocept, Inc.	02/04
Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index	24-10-23
Biocept, Inc.(NasdaqCM:BIOC) dropped from S&P TMI Index	19-10-23
Biocept : Bankruptcy - Form 8-K	16-10-23
Biocept, Inc. Filed for Bankruptcy	13-10-23
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide Assay to Evaluate Patients with Leptomeningeal Metastases	22-09-23
Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases	21-09-23
Biocept, Inc. Announces the Full Enrollment of 40 Subjects with Breast or Non-Small Cell Lung Cancer	21-09-23
Biocept Signs CNSide Licensing Agreement with plus Therapeutics	11-09-23
Sector Update: Health Care Stocks Slipping Late Friday8 Afternoon	08-09-23
Sector Update: Health Care Stocks Slipping Friday Afternoon	08-09-23
Sector Update: Health Care	08-09-23
Biocept Signs Non-Exclusive Licensing Agreement With Plus Therapeutics on CNSide Tumor Cell Platform	08-09-23
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	08-09-23
Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics	08-09-23
Top Premarket Gainers	08-09-23
Plus Therapeutics, Inc. Enters into License Agreement with Biocept for Cerebrospinal Fluid Tumor Cell Enumeration Assay	08-09-23
Biocept to Participate in the H.C. Wainwright Global Investment Conference	05-09-23
Biocept to Hold Business Update Conference Call on August 30, 2023	28-08-23
Biocept to Hold Business Update Conference Call on August 30, 2023	25-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Biocept, Inc.

Aandelen

BIOCQ

US09072V6002

Andere talen

Filters